Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
- Published in:
- Clinical Science, 2017, v. 131, n. 5, p. 395, doi. 10.1042/CS20160413
- By:
- Publication type:
- Article
Works matching IS 01435221 AND DT 2017 AND VI 131 AND IP 5
Results: 6
1
2
miR-378 reduces mesangial hypertrophy and kidney tubular fibrosis via MAPK signalling.
- Published in:
- Clinical Science, 2017, v. 131, n. 5, p. 411, doi. 10.1042/CS20160571
- By:
- Publication type:
- Article
3
HMGB1-induced autophagy: a new pathway to maintain Treg function during chronic hepatitis B virus infection.
- Published in:
- Clinical Science, 2017, v. 131, n. 5, p. 381, doi. 10.1042/CS20160704
- By:
- Publication type:
- Article
4
Endothelial cell-oligodendrocyte interactions in small vessel disease and aging.
- Published in:
- Clinical Science, 2017, v. 131, n. 5, p. 369, doi. 10.1042/CS20160618
- By:
- Publication type:
- Article
5
RNA splicing in human disease and in the clinic.
- Published in:
- Clinical Science, 2017, v. 131, n. 5, p. 355, doi. 10.1042/CS20160211
- By:
- Publication type:
- Article
6
GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction.
- Published in:
- Clinical Science, 2017, v. 131, n. 5, p. 343, doi. 10.1042/CS20160803
- By:
- Publication type:
- Article